170 related articles for article (PubMed ID: 6335053)
1. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
[TBL] [Abstract][Full Text] [Related]
2. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
3. Importance of platelet-free preparations for evaluating lymphocyte nucleotide levels in inherited or acquired immunodeficiency syndromes.
Goday A; Simmonds HA; Webster DR; Levinsky RJ; Watson AR; Hoffbrand AV
Clin Sci (Lond); 1983 Dec; 65(6):635-43. PubMed ID: 6414755
[TBL] [Abstract][Full Text] [Related]
4. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
5. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency.
Simmonds HA; Levinsky RJ; Perrett D; Webster DR
Biochem Pharmacol; 1982 Mar; 31(6):947-51. PubMed ID: 7082375
[TBL] [Abstract][Full Text] [Related]
7. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM; Henderson JF
Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
[TBL] [Abstract][Full Text] [Related]
8. Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells.
Koller CA; Orringer EP; Berkowitz LR; Mulhern AT
Prog Clin Biol Res; 1984; 165():227-39. PubMed ID: 6334314
[No Abstract] [Full Text] [Related]
9. Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
Bory C; Boulieu R; Souillet G; Chantin C; Rolland MO; Mathieu M; Hershfield M
Pediatr Res; 1990 Aug; 28(2):127-30. PubMed ID: 2395602
[TBL] [Abstract][Full Text] [Related]
10. B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency.
Goday A; Simmonds HA; Fairbanks LD; Morris GS
Adv Exp Med Biol; 1986; 195 Pt A():515-20. PubMed ID: 3487922
[No Abstract] [Full Text] [Related]
11. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
12. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
13. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
Schwartz AL; Polmar SH; Stern RC; Cowan DH
Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
[TBL] [Abstract][Full Text] [Related]
14. Purine metabolism in adenosine deaminase deficiency.
Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
[TBL] [Abstract][Full Text] [Related]
15. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
[TBL] [Abstract][Full Text] [Related]
16. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
17. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
[TBL] [Abstract][Full Text] [Related]
18. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
